Amyopathic dermatomyositis with lung involvement responsive to mycophenolate mofetil

Immunopharmacology and Immunotoxicology

Volumn 35, Issue 6, 2013, Pages 687-692

  Cozzani, Emanuele ^a   Cinotti, Elisa ^a   Felletti, Raffaella ^a   Pelucco, David ^a   Rebora, Alfredo ^a   Parodi, Aurora ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Autoimmune disease; Connective tissue disease; Corticosteroids; Lung involvement; Therapy

Indexed keywords

MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ADULT; AMYOPATHIC DERMATOMYOSITIS; ARTICLE; CASE REPORT; DERMATOMYOSITIS; DRUG EFFICACY; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG COMPLICATION; LUNG FUNCTION TEST; MALE; PNEUMOMEDIASTINUM; PRIORITY JOURNAL; REMISSION; TREATMENT RESPONSE;

ADULT; DERMATOMYOSITIS; ENZYME INHIBITORS; HUMANS; LUNG DISEASES, INTERSTITIAL; MALE; MEDIASTINAL EMPHYSEMA; MYCOPHENOLIC ACID;

EID: 84887949089     PISSN: 08923973     EISSN: 15322513     Source Type: Journal    
DOI: 10.3109/08923973.2013.833624     Document Type: Article

References (29)

1. Yamasaki Y, Yamada H, Ohkubo M, et al. Longterm survival and associated risk factors in patients with adult-onset idiopathic inflammatory myopathies and amyopathic dermatomyositis: experience in a single institute in Japan. J Rheumatol 2011;38: 1636-1643.
2. Suda T, Fujisawa T, Enomoto N, et al. Interstitial lung diseases associated with amyopathic dermatomyositis. Eur Respir J 2006;28: 1005-1012. (Pubitemid 46331972)
3. Yamanishi Y, Maeda H, Konishi F, et al. Dermatomyositis associated with rapidly progressive fatal interstitial pneumonitis and pneumomediastinum. Scand J Rheumatol 1999;28:58-61. (Pubitemid 29125231)
4. Steen VD, Lanz Jr JK, Conte C, et al. Therapy for severe interstitial lung disease in systemic sclerosis. A retrospective study. Arthritis Rheum 1994;37:1290-1296. (Pubitemid 24320745)
5. Swigris JJ, Olson AL, Fischer A, et al. Mycophenolate mofetil is safe, well tolerated, and preserves lung function in patients with connective tissue disease-related interstitial lung disease. Chest 2006;130:30-36. (Pubitemid 44116838)
6. Saketkoo LA, Espinoza LR. Experience of mycophenolate mofetil in 10 patients with autoimmune-related interstitial lung disease demonstrates promising effects. Am J Med Sci 2009;337:329-335.
7. Morganroth PA, Kreider ME, Werth VP. Mycophenolate mofetil for interstitial lung disease in dermatomyositis. Arthritis Care Res (Hoboken) 2010;62:1496-1501.
8. Tsuchiya H, Tsuno H, Inoue M, et al. Mycophenolate mofetil therapy for rapidly progressive interstitial lung disease in a patient with clinically amyopathic dermatomyositis. Mod Rheumatol 2013 Apr 25. [Epub ahead of print].
9. Matsuda Y, Tomii M, Kashiwazaki S. Fatal pneumomediastinum in dermatomyositis without creatine kinase elevation. Intern Med 1993;32:643-647.
10. Isfer RS, Nakao SK, Cernea SS. Dermatomyositis associated with pneumomediastinum and subcutaneous cellular tissue emphysema. Br J Rheumatol 1994;33:1092-1096.
11. Bousquet E, Rolland Y, Bon E, et al. Pneumomediastinum, a rare complication of dermatomyositis. Rev Rheum Engl Ed 1996;63:457-460.
12. Santiago MB, Chalhoub M, Pereira ST. Amyopathic dermatomyositis complicated by interstitial pulmonary disease and pneumomediastinum. J Rheumatol 1998;25:10.
13. Jansen TL, Barrera P, van Engelen BG, et al. Dermatomyositis with subclinical myositis and spontaneous pneumomediastinum with pneumothorax: case report and review of the literature. Clin Exp Rheumatol 1998;16:733-735.
14. Barvaux VA, Mullem XV, Pieters T, Houssiau FA. Persistent pneumomediastinum and dermatomyositis: A case report and review of the literature. Clin Rheumatol 2001;20:359-361. (Pubitemid 32936799)
15. Lee CS, Chen TL, Tzen CY, et al. Idiopathic inflammatory myopathy with diffuse alveolar damage. Clin Rheumatol 2002;21:391-396.
16. Miyake S, Ohtani Y, Sawada M, et al. Usefulness of cyclosporine A on rapidly progressive interstitial pneumonia in dermatomyositis. Sarcoidosis Vasc Diffuse Lung Dis 2002;19:128-133. (Pubitemid 34685912)
17. De Maupeou F, Chiavassa-Gandois H, Giron J, et al. Spontaneous pneumomediastinum in dermatomyositis: A pathophysiological approach. Rev Mal Respir 2003;20:965-968. (Pubitemid 38133211)
18. Cottin V, Thivolet-Béjui F, Reynaud-Gaubert M, et al. Interstitial lung disease in amyopathic dermatomyositis, dermatomyositis and polymyositis. Eur Respir J 2003;22:245-250. (Pubitemid 36986992)
19. Kameda H, Nagasawa H, Ogawa H, et al. Combination therapy with corticosteroids, cyclosporin A, and intravenous pulse cyclophosphamide for acute/subacute interstitial pneumonia in patients with dermatomyositis. J Rheumatol 2005;32:1719-1726. (Pubitemid 41324810)
20. Powell C, Kendall B, Wernick R, Heffner JE. A 34-year-old man with amyopathic dermatomyositis and rapidly progressive dyspnea with facial swelling: diagnosis. Pneumomediastinum and subcutaneous emphysema secondary to amyopathic dermatomyositis-associated interstitial lung disease. Chest 2007;132:1710-1713.
21. Miyazaki E, Ando M, Muramatsu T, et al. Early assessment of rapidly progressive interstitial pneumonia associated with amyopathic dermatomyositis. Clin Rheumatol 2007;26:436-439. (Pubitemid 46486980)
22. Yamasaki Y, Yamada H, Yamasaki M, et al. Intravenous cyclophosphamide therapy for progressive interstitial pneumonia in patients with polymyositis/dermatomyositis. Rheumatology (Oxford) 2007;46:124-130. (Pubitemid 44932799)
23. Park SH, Kum YS, Kim KC, et al. Pneumomediastinum and subcutaneous emphysema secondary to amyopathic dermatomyositis with cryptogenic organizing pneumonia in invasive breast cancer: A case report and review of literature. Rheumatol Int 2009;29:1231-1235.
24. Suzuki Y, Hayakawa H, Miwa S, et al. Intravenous immunoglobulin therapy for refractory interstitial lung disease associated with polymyositis/ dermatomyositis. Lung 2009;187:201-206.
25. Mukae H, Ishimoto H, Sakamoto N, et al. Clinical differences between interstitial lung disease associated with clinically amyopathic dermatomyositis and classic dermatomyositis. Chest 2009;136:1341-1347.
26. Jamoussi SK, Dhaou BB, Boussema F, et al. Interstitial pneumonia complicating amyopathic dermatomyositis: A case report. Rev Pneumol Clin 2009;65:353-356.
27. Ando M, Miyazaki E, Yamasue M, et al. Successful treatment with tacrolimus of progressive interstitial pneumonia associated with amyopathic dermatomyositis refractory to cyclosporine. Clin Rheumatol 2010;29:443-445.
28. Kawashima T, Wakabayashi T, Kuroda T, et al. Lecithinized superoxide dismutase treatment improves steroid-refractory interstitial pneumonia. Respirol Carlton Vic 2010;15:1261-1265.
29. Nguyen H, Le C, Nguyen H. Acute lyme infection presenting with amyopathic dermatomyositis and rapidly fatal interstitial pulmonary fibrosis: A case report. J Med Case Rep 2010;4:187.